4381874 Canada Inc. Announces Acquisition of Shares of Global SeaFarms Corporation Under a Private Placement
October 10, 2013 16:30 ET
|
4381874 Canada Inc.
MONTREAL, QUEBEC--(Marketwired - Oct. 10, 2013) - 4381874 Canada Inc. announced that it has acquired the ownership of 333,333 class A shares (the "Class A Shares") of Global SeaFarms...
Robert Manherz: Announcement
August 12, 2013 07:19 ET
|
Robert Manherz
ANCASTER, ONTARIO--(Marketwired - Aug. 12, 2013) - Robert Manherz, a director of CO2 Solutions Inc. (the "Corporation"), announced today that he has acquired an additional interest in the...
Thallion Pharmaceutiques annonce une composante au comptant de 0,1889 $ par action
August 09, 2013 08:00 ET
|
Thallion Pharmaceutiques Inc.;BELLUS Santé inc.
MONTRÉAL, QUÉBEC--(Marketwired - 9 août 2013) - Thallion Pharmaceutiques Inc. (TSX CROISSANCE:TLN) (« Thallion ») et BELLUS Santé inc. (TSX:BLU) («...
Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share
August 09, 2013 08:00 ET
|
Thallion Pharmaceuticals Inc.;BELLUS Health Inc.
MONTREAL, QUEBEC--(Marketwired - Aug. 9, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU) ("BELLUS Health") announced today that in...
Thallion annonce l'approbation du plan d'arrangement par les actionnaires ainsi que la date et l'heure de l'audience de la requête pour ordonnance définitive de la Cour
August 06, 2013 17:00 ET
|
Thallion Pharmaceutiques Inc.;BELLUS Santé inc.
MONTRÉAL, QUÉBEC--(Marketwired - 6 août 2013) - Thallion Pharmaceutiques Inc. (TSX CROISSANCE:TLN) (« Thallion ») et BELLUS Santé inc. (TSX:BLU) («...
Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order
August 06, 2013 17:00 ET
|
Thallion Pharmaceuticals Inc.;BELLUS Health Inc.
MONTRÉAL, QUÉBEC--(Marketwired - Aug. 6, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU) ("BELLUS Health") announced today...
RETRANSMISSION/Thallion Pharmaceutiques annonce une encaisse nette à la date d'effet minimale de 7 500 000 $, ce qui représente une composante au comptant d'au moins 0,1765 $ par action
August 02, 2013 10:54 ET
|
Thallion Pharmaceutiques Inc.;BELLUS Santé inc.
MONTRÉAL, QUEBEC--(Marketwired - 2 août 2013) - Thallion Pharmaceutiques Inc. (« Thallion ») (TSX CROISSANCE:TLN) et BELLUS Santé inc. (TSX:BLU) (« BELLUS...
RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share
August 02, 2013 10:53 ET
|
Thallion Pharmaceuticals Inc.;BELLUS Health Inc.
MONTREAL, QUEBEC--(Marketwired - Aug. 2, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU) ("BELLUS Health") announced today that in...
Thallion Pharmaceutiques annonce une encaisse nette à la date d'effet minimale de 7 500 000 $, ce qui représente une composante au comptant d'au moins 0,1765 $ par action
August 02, 2013 08:00 ET
|
Thallion Pharmaceutiques Inc.
MONTRÉAL, QUEBEC--(Marketwired - 2 août 2013) - Thallion Pharmaceutiques Inc. (« Thallion ») (TSX CROISSANCE:TLN) et BELLUS Santé inc. (TSX:BLU) (« BELLUS...
Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share
August 02, 2013 08:00 ET
|
Thallion Pharmaceuticals Inc.
MONTREAL, QUEBEC--(Marketwired - Aug. 2, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU) ("BELLUS Health") announced today that in...